CLINICAL TRIALS PROFILE FOR FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE

All Clinical Trials for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02168478 ↗	Neo-Synalar Modified 48 Hour Patch Test	Completed	Noah Rosenberg, MD	Phase 4	2014-06-01	A 48 hour patch test performed in healthy volunteers to determine the presensitization (pre-existing allergy) of Neo-Synalar (neomycin sulfate 0.5%(0.35% neomycin base), fluocinolone acetonide 0.025%) Cream . Subjects also receive a positive control (Sodium Lauryl Sulfate) and a negative control (Saline). The primary objective of this study is to determine if any subjects exhibit an allergic reaction which may be indicative of a pre-existing sensitization.

Clinical Trial Conditions for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE

Condition Name

Condition Name for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
Intervention	Trials
Allergy	1

Condition MeSH

Condition MeSH for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
Intervention	Trials

Clinical Trial Locations for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE

Trials by Country

Trials by Country for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
Location	Trials
United States	1

Trials by US State

Trials by US State for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
Location	Trials
New Jersey	1

Clinical Trial Progress for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE

Clinical Trial Phase

Clinical Trial Phase for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
Clinical Trial Phase	Trials
Phase 4	1

Clinical Trial Status

Clinical Trial Status for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
Clinical Trial Phase	Trials
Completed	1

Clinical Trial Sponsors for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE

Sponsor Name

Sponsor Name for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
Sponsor	Trials
Noah Rosenberg, MD	1

Sponsor Type

Sponsor Type for FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
Sponsor	Trials
Industry	1